期刊文献+

AECOPD与哮喘急性发作患者血清MMP-9、TIMP-1、IL-17水平的研究 被引量:10

MMP-9,TIMP-1 and IL-17 in serum of patients with AECOPD and acute asthma attack
下载PDF
导出
摘要 目的研究AECOPD患者与哮喘急性发作患者血清MMP-9、TIMP-1、IL-17的水平。方法检测并比较2009年8月~2011年8月期间我院呼吸内科收治的22例AECOPD患者、18例哮喘急性发作患者及16例健康体检者的血清基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶抑制剂-1(TIMP-1)、白介素-17(IL-17)水平。结果 AECOPD组及哮喘急性发作组血清MMP-9、TIMP-1、MMP-9/TIMP-1比值、IL-17水平均高于健康对照组,差异有统计学意义;AECOPD组患者血清MMP-9、TIMP-1、IL-17水平均高于哮喘急性发作组,而MMP-9/TIMP-1比值低于哮喘急性发作组,差异有统计学意义。结论 AECOPD患者与哮喘急性发作患者血清MMP-9、TIMP-1、IL-17水平升高,且AECOPD患者的血清MMP-9、TIMP-1、IL-17水平高于哮喘急性发作患者。 Objectives To investigate the level of MMP-9、TIMP-1、IL-17 in serum of patients with AECOPD and acute asthma attack.Methods Detected and compared MMP-9,TIMP-1 and IL-17 levels in the serum of 16 healthy persons,22 AECOPD patients and18 acute asthma attack cases admitted to the Respiratory Department in Anqing hospital affiliated of Anhui Medical University and from August 2009 to August 2011.Results Level of MMP-9,TIMP-1,MMP-9/TIMP-1 and IL-17 in AECOPD and acute asthma attack groups were higher than those in healthy group.Level of MMP-9,TIMP-1 and IL-17 in AECOPD group were higher than those in acute asthma attack group,while level of MMP-9/TIMP-1 in AECOPD group was lower than that in acute asthma attack group.The difference was statistically significant.Conclusion Level of MMP-9,TIMP-1 and IL-17 in both AECOPD and acute asthma attack patients increased and level of MMP-9,TIMP-1,IL-17 in AECOPD are higher than those in acute asthma attack.
出处 《临床肺科杂志》 2012年第4期614-615,共2页 Journal of Clinical Pulmonary Medicine
关键词 MMP-9 TIMP-1 IL-17 血清 AECOPD 哮喘急性发作 MMP-9 TIMP-1 IL-17 serum AECOPD acute asthma attack
  • 相关文献

参考文献8

二级参考文献59

共引文献50

同被引文献63

  • 1何智辉,陈平.慢性阻塞性肺疾病患者体内白介素-6和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26(7):989-991. 被引量:50
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 3Brajer B,Batura - Gahryel H,Nowicha A,et al. Concentration of ma-trix metailoproteinase -9 in serum of patients with chronic obstructivepulmonary disease and a degree of airway obstruction and disease pro-gression [J]. J Physiol Pharmacol,2008,59(Suppl6) : 145 -152.
  • 4Volanakis J. Human C-reactive protein:expression, structure and function [J]. Mol Immunol,2005 ;38 (2) : 189 - 197.
  • 5Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease[J]. Respiratory Medicine, 1998 ;92(4) :664 -667.
  • 6KomiyamaY, Nakae S, M atsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomy- elitis [ J ]. J Immunol, 2006, 177 ( 1 ) : 566 - 573.
  • 7Keating VM, Collins PD, Scott DM, et al. Diferences in interleukin- 8 and tumor necrosis factor-c induced sputum from patients with chronic obstructive pulmonary disease or asthma[ J]. Am J Respir Crit Care Med ,2006,153:530 - 534.
  • 8Hageman GJ, Larik I, Pennings HJ, et al. Systemic poly ( ADP-ri- bose) Polymerase-1 activation,chronic inflammation, and oxida- tive stress in COPD patients[ J]. Free Radic Biol Med, 2003 ;35 (2) :140-148.
  • 9庞敏,王海龙,许建英,王春芳,赵俊萍,辛海峰,刘飞君,马韬.N-乙酰半胱氨酸对COPD大鼠Clara细胞及CC16的影响[J].中国病理生理杂志,2008,24(1):20-23. 被引量:17
  • 10Gholadi H, D>uladi N, Beukaghazadeh K, et al. Ass*miation of High Sensitive CRP Level and COPD Assessmen! Test Seores with Clinically Important Predietlve Outcomes in Stable COPD Patients[J ]. Tanaffos, 2015, 14 (1):34-41.

引证文献10

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部